Shelf life – Page 2 – Pharma.Tips

How to Prepare Ongoing Stability Data for Regulatory Inspection

Steps to Prepare for Regulatory Inspections of Ongoing Stability Programs In the fast-evolving pharmaceutical landscape, a robust ongoing stability program is pivotal for ensuring product efficacy and compliance. However, gaps…

How to Train QA Teams to Review ICH Q1D Stability Designs

Addressing Bracketing and Matrixing Misuse in Stability Studies In the pharmaceutical industry, the correct implementation of stability studies is vital for ensuring product quality and compliance with regulatory standards. A…

Ongoing Stability Program Failures Due to Inadequate Protocols

Addressing Failures in Ongoing Stability Programs Due to Insufficient Protocols In the pharmaceutical industry, ongoing stability program failures present significant challenges, particularly when driven by inadequate protocols. These failures can…

Bracketing and Matrixing CAPA After Regulatory Deficiency Letters

Addressing Compliance Issues Related to Bracketing and Matrixing in Stability Studies In the lifecycle of pharmaceutical products, stability studies are essential to ensure that products maintain their safety, efficacy, and…

How to Align Ongoing Stability with ICH and Regional Expectations

Aligning Ongoing Stability with ICH and Regional Standards The pharmaceutical industry faces numerous challenges related to compliance with International Council for Harmonisation (ICH) guidelines while managing ongoing stability programs. Recognizing…

Why Matrixing May Hide Early Degradation Trends

Addressing the Challenges of Matrixing in Stability Studies In pharmaceutical stability studies, matrixing is often employed as a strategy to optimize study designs and reduce resource expenditure. However, its potential…

Ongoing Stability Gaps in Temperature Excursion Impact Assessment

Addressing Gaps in Ongoing Stability Programs for Temperature Excursion Impact Assessment In the pharmaceutical manufacturing environment, maintaining the integrity of stability studies is vital to ensure product quality and regulatory…

Reduced Stability Testing Designs for Global Registrations: Risk Points

Managing Bracketing and Matrixing Misuse in Stability Testing: Effective Strategies In the complex world of pharmaceutical stability testing, the misuse of bracketing and matrixing designs can lead to serious regulatory…

How to Manage Ongoing Stability for Multiple Manufacturing Sites

Addressing Gaps in Ongoing Stability Programs Across Manufacturing Sites Managing ongoing stability programs is crucial for ensuring that pharmaceutical products meet quality standards throughout their shelf life. Companies often grapple…

How to Use Prior Knowledge in Bracketing and Matrixing Decisions

Understanding and Leveraging Prior Knowledge to Mitigate Bracketing and Matrixing Misuse In the realm of stability studies, the correct application of bracketing and matrixing techniques is vital for ensuring product…

How to Audit an Ongoing Stability Program Effectively

Effectively Auditing Ongoing Stability Programs to Identify Gaps Pharmaceutical stability programs are essential for ensuring the quality and efficacy of drug products throughout their shelf life. However, ongoing stability program…

Bracketing Justification After Manufacturing Site Transfer

Understanding Bracketing Justification Following a Manufacturing Site Transfer Bracketing and matrixing misuse in pharmaceutical manufacturing can result in significant regulatory scrutiny, especially after a site transfer. This issue highlights the…